RecruitingNCT07103317

Comprehensive Coronary Physiology in Patients With Angina With Nonobstructive Coronary Arteries - Czech Republic

Comprehensive COROnary PHYSiology Assessment in Patients With Angina With Nonobstructive Coronary Arteries - CZECH Republic (CoroPhys-CZECH)


Sponsor

University Hospital, Motol

Enrollment

1,000 participants

Start Date

Apr 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary artery disease (CAD) is a leading cause of morbidity and mortality. While cardiologists have been focused on discrete, visible stenoses of coronary arteries, there is increasing awareness of the importance of microcirculation and vasospastic disorders in causing angina. The microvascular bed is composed of vessels smaller than 400 microns in diameter. Their network is significantly larger than that of the epicardial vessels and serves essential functions, including regulating myocardial blood flow and cellular metabolism. Angina pectoris, a most frequent symptom of CAD or myocardial ischemia, was assumed to be caused by significant stenosis of the epicardial coronary artery. However, it was found that in over 50% of cases, there was no obstructive CAD, which is described as angina with no obstructive coronary arteries (ANOCA) or ischemia with no obstructive coronary arteries (INOCA), according to the clinical setting.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Adults of both sexes older than 18 years
  • Angina symptoms or angina equivalent
  • Referred to cath lab for evaluation of CAD
  • Invasive physiology testing performed (microcirculation testing +/- vasospasm testing)

Exclusion Criteria3

  • Persons under the age of 18
  • Pregnant of nursing
  • No coronary physiology measurements were performed

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

University Hospital Motol

Prague, Česká Republika, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07103317


Related Trials